Corvel vs Guardant Health
Corvel and Guardant Health are similar in size: $959m and $982m of revenue in their latest fiscal years. Guardant Health grew faster (32.9% against 7.0%). Corvel kept more of each dollar of sales as profit: a net margin of 11.5% against -42.4%.
| Latest fiscal year | CorvelCRVL, 2026 | Guardant HealthGH, 2025 |
|---|---|---|
| Revenue | $959m | $982m |
| Revenue growth | 7.0% | 32.9% |
| Net income | $110m | −$416m |
| Operating margin | — | -44.5% |
| Net margin | 11.5% | -42.4% |
| Return on equity | 30.8% | — |
| Free cash flow | $110m | −$233m |
| Cash | $233m | $378m |
| Total debt | $0 | $1.50bn |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $56.2m | $45.0m |
| Employees | 5,239 | 2,506 |
| Market value | $4.20bn | $23.34bn |
| Price vs our value range | — | — |
| Moat score | 68 (Moderate) | 8 (Weak) |
| Insider trades, 12 months | 0 buys, 26 sales | 1 buys, 141 sales |